This case highlights how the exenatide patent filed by Amylin Pharmaceuticals led to a detailed examination of inventive step, therapeutic efficacy, and Section 3(d) objections, culminating in a significant Delhi High Court judgment in Nov. 2025
In the case of Allergan vs. Sandoz, the United States Court of Appeals for the Federal Circuit (CAFC) has invalidated a key Allergan patent covering the use of prostaglandin F (PGF) analogs for hair growth, handing a significant win to generic manufacturer Sandoz Inc.
In a landmark decision concerning SPC for Durvalumab, the District Court of The Hague upheld the Dutch Intellectual Property Office’s (IPO) refusal to grant a Supplementary Protection Certificate (SPC) for AstraZeneca’s cancer immunotherapy drug Durvalumab, marketed as Imfinzi®. Durvalumab is an anti-PD-L1 antibody used in treating various cancers, and the refusal of SPC status has … Read more
Meta Platforms, Inc., the parent company of Facebook, filed a petition with the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB) on November 10, 2025, seeking to invalidate all claims of SitNet’s U.S. Patent No. 12,256,463 B2. Basic Details of the Petition: Basic information of the Patent (463)? The 463 patent claims … Read more
If you have ever wondered why some days feel more stressful than others even when you sleep well? In the recent development there’s exciting news from the world of health tech, Ultrahuman’s Next-Gen Wearables: Files Patent for Physiological Stress Monitoring System, introducing a smart real-time monitoring technology that tracks stress by analyzing your body’s natural … Read more
On Nov 5, 2025, the Patents Court handed down an important interim injunction decision in Dr Reddy’s Laboratories (UK) Ltd v Boehringer Ingelheim International GmbH, neutral citation EWHC 2834 (Pat). Michael Tappin KC, sitting as a Deputy Judge, granted interim relief restraining Dr Reddy’s from dealing in empagliflozin (the active in Jardiance) in the UK … Read more
In the case Merck Serono S.A. v. Hopewell Pharma Ventures, Inc., the Federal Circuit upheld a Patent Trial and Appeal Board decision invalidating claims related to Merck’s multiple sclerosis drug Mavenclad, an oral formulation of the compound Cladribine. Merck Serono S.A. v. Hopewell Pharma Ventures, Inc. – Basic Details: Merck Serono S.A. v. Hopewell Pharma … Read more
A recent Delhi High Court judgment in Zeria Pharmaceutical Co. Ltd. vs. The Controller of Patents (C.A.(COMM.IPD-PAT) 452/2022) delivers a message to the pharmaceutical industry: a higher yield and greater purity are not enough to secure a patent in India. Zeria’s patent application for a novel intermediate compound was rejected by the Indian Patent Office, … Read more
